We are live on
!
Find out more
SR
Summer Road Portfolio holdings
AUM
$142M
1-Year Est. Return
43.61%
This Fund
S&P 500
This Quarter
Est. Return
-32.29%
1 Year Est. Return
+43.61%
3 Year Est. Return
+101.14%
5 Year Est. Return
-35.41%
10 Year Est. Return
+349.33%
AUM
$17.2M
AUM Growth
-$8.09M
(-32%)
Cap. Flow
+$90.5K
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ocular Therapeutix
OCUL
|
+$90.5K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ocular Therapeutix
OCUL
$1.96B
| $17.2M | 100% |
6,122,089
+27,328
| +0.4% | +$90.5K |
|
Similar funds
EC
TA
AC
ACP
PC
YEPX
ALM
BRIA
Summer Road's Q4 2022 Portfolio in Review
As of Q4 2022, Summer Road held 1 position worth $17.2M, down 32% from $25.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 0%. Summer Road opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Summer Road added most to Ocular Therapeutix in Q4 2022, an estimated $90.5K increase.
- Summer Road's ten largest holdings make up 100% of its $17.2M portfolio in Q4 2022.
- Summer Road opened 0 new positions and closed 0 in Q4 2022.
- Summer Road's portfolio value fell 32% quarter-over-quarter to $17.2M.
Based on Summer Road's 13F filing for Q4 2022, filed 14 Feb 2023.